ADHD: Willpower or Meds?

Psychiatrists and parents are often torn over giving psychostimulants to children suffering from attention-deficit/hyperactivity disorder (ADHD). The finding that kids with ADHD are reluctant to credit medication for their behavioral improvement won't do much to resolve this controversy.

Jason J. Washburn, a postdoctoral fellow at the University of Michigan, asked children treated for ADHD and their parents what made a difference in the child's behavior: Was it the pill, the child or both?

The answer depends on whom you ask, says Washburn, in his study of 8- to 13-year-olds.

Parents and children attributed positive results to both the medication and efforts by the child. However, parents were likely to give more credit to the medication, while children gave more credit to themselves.

The findings are encouraging, says Washburn. "When these children go on medication, parents are often concerned that daily pill-taking will damage the child's self-esteem and that they will feel helpless without the medication," he says. "Our findings show that children don't ask, 'Is it the pill or me?' They say, 'It's the pill and me.' "

Tags: ADHD, attention deficit hyperactivity, attention deficit hyperactivity disorder, attention deficit hyperactivity disorder adhd, behavior, children, controversy, deficit hyperactivity disorder, deficit hyperactivity disorder adhd, drug, parents, postdoctoral fellow, psychostimulants, ritalin, self esteem, university of michigan, washburn

Current Issue

Everyday Creativity

How to start living creatively and reap the benefits.

Find a Therapist

Search our customized Directory for a licensed professional near you.
The Favorite Child

Discover how being the favorite child can confer both great advantages and significant emotional handicaps.
Read more...
Saybrook University
Pursue advanced degrees in Mind-Body Medicine and Psychology. Learn more.
Read more...
Kyolic Formula 109
Kyolic Formula 109 promotes healthy blood pressure and reduces stress by supporting relaxing.
Read more...